{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T05:49:48Z","timestamp":1773467388567,"version":"3.50.1"},"reference-count":35,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1518,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1111\/j.1365-2265.2011.04032.x","type":"journal-article","created":{"date-parts":[[2011,3,2]],"date-time":"2011-03-02T00:52:21Z","timestamp":1299027141000},"page":"247-254","source":"Crossref","is-referenced-by-count":31,"title":["Use of sodium iodide symporter expression in differentiated thyroid carcinomas"],"prefix":"10.1111","volume":"75","author":[{"given":"Elaine C.","family":"Morari","sequence":"first","affiliation":[]},{"given":"Marjory A.","family":"Marcello","sequence":"additional","affiliation":[]},{"given":"Ana Carolina T.","family":"Guilhen","sequence":"additional","affiliation":[]},{"given":"Lucas L.","family":"Cunha","sequence":"additional","affiliation":[]},{"given":"Paulo","family":"Latuff","sequence":"additional","affiliation":[]},{"given":"Fernando A.","family":"Soares","sequence":"additional","affiliation":[]},{"given":"Jos\u00e9","family":"Vassallo","sequence":"additional","affiliation":[]},{"given":"Laura S.","family":"Ward","sequence":"additional","affiliation":[]}],"member":"311","published-online":{"date-parts":[[2011,7,6]]},"reference":[{"key":"10.1111\/j.1365-2265.2011.04032.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1590\/S0004-27302008000900018","article-title":"Thyroid cancer: increased occurrence of the disease or simply in its detection?","volume":"52","author":"Ward","year":"2008","journal-title":"Arquivos Brasileiros de Endocrinologia e Metabologia"},{"key":"10.1111\/j.1365-2265.2011.04032.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.amjsurg.2009.11.008","article-title":"Improved detection does not fully explain the rising incidence of well-differentiated thyroid cancer: a population-based analysis","volume":"200","author":"Morris","year":"2010","journal-title":"American Journal of Surgery"},{"key":"10.1111\/j.1365-2265.2011.04032.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.clon.2010.05.004","article-title":"Thyroid cancer epidemiology and prognostic variables","volume":"22","author":"Sipos","year":"2010","journal-title":"Clinical Oncology (Royal College of Radiologists (Great Britain))"},{"key":"10.1111\/j.1365-2265.2011.04032.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1210\/jc.2009-1536","article-title":"Are the Clinical and pathological features of differentiated thyroid carcinoma really changed over the last 35 years? Study on 4187 patients from a single Italian institution to answer this question","volume":"95","author":"Elisei","year":"2010","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1111\/j.1365-2265.2011.04032.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1210\/jc.2005-1322","article-title":"Survival and death causes in differentiated thyroid carcinoma","volume":"91","author":"Eustatia-Rutten","year":"2006","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1111\/j.1365-2265.2011.04032.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.mce.2003.10.059","article-title":"Advances in Na(+)\/I(-) symporter (NIS) research in the thyroid and beyond","volume":"213","author":"Dohan","year":"2003","journal-title":"Molecular and Cellular Endocrinology"},{"key":"10.1111\/j.1365-2265.2011.04032.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/0002-9343(94)90321-2","article-title":"Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer","volume":"97","author":"Mazzaferri","year":"1994","journal-title":"The American Journal of Medicine"},{"key":"10.1111\/j.1365-2265.2011.04032.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"4092","DOI":"10.1210\/jc.86.9.4092","article-title":"Outcome of differentiated thyroid cancer with detectable serum Tg and negative diagnostic (131)I whole body scan: comparison of patients treated with high (131)I activities versus untreated patients","volume":"86","author":"Pacini","year":"2001","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1111\/j.1365-2265.2011.04032.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1507\/endocrj.K08E-166","article-title":"Prognostic factors and therapeutic strategies for differentiated carcinomas of the thyroid","volume":"56","author":"Ito","year":"2009","journal-title":"Endocrine Journal"},{"key":"10.1111\/j.1365-2265.2011.04032.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0304-3835(03)00392-6","article-title":"Low expression of sodium iodide symporter identifies aggressive thyroid tumors","volume":"200","author":"Ward","year":"2003","journal-title":"Cancer Letters"},{"key":"10.1111\/j.1365-2265.2011.04032.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"4141","DOI":"10.1210\/jc.2007-0353","article-title":"Association of low sodium-iodide symporter messenger ribonucleic acid expression in malignant thyroid nodules with increased intracellular protein staining","volume":"93","author":"Sodre","year":"2008","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1111\/j.1365-2265.2011.04032.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/379458a0","article-title":"Cloning and characterization of the thyroid iodide transporter","volume":"379","author":"Dai","year":"1996","journal-title":"Nature"},{"key":"10.1111\/j.1365-2265.2011.04032.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s002590100509","article-title":"Relationship between expression of the sodium\/iodide symporter and 131I uptake in recurrent lesions of differentiated thyroid carcinoma","volume":"28","author":"Min","year":"2001","journal-title":"European Journal of Nuclear Medicine"},{"key":"10.1111\/j.1365-2265.2011.04032.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"5627","DOI":"10.1210\/jc.86.11.5627","article-title":"Immunohistochemical analysis of sodium iodide symporter expression in metastatic differentiated thyroid cancer: correlation with radioiodine uptake","volume":"86","author":"Castro","year":"2001","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1111\/j.1365-2265.2011.04032.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/BF03347392","article-title":"Relationship of sodium\/iodide symporter expression with I131 whole body scan uptake between primary and metastatic lymph node papillary thyroid carcinomas","volume":"30","author":"Lee","year":"2007","journal-title":"Journal of Endocrinological Investigation"},{"key":"10.1111\/j.1365-2265.2011.04032.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1530\/EJE-08-0505","article-title":"Immunoanalysis indicates that the sodium iodide symporter is not overexpressed in intracellular compartments in thyroid and breast cancers","volume":"160","author":"Peyrottes","year":"2009","journal-title":"European Journal of Endocrinology"},{"key":"10.1111\/j.1365-2265.2011.04032.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1089\/thy.2009.0110","article-title":"Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer","volume":"19","author":"Cooper","year":"2009","journal-title":"Thyroid"},{"key":"10.1111\/j.1365-2265.2011.04032.x-BIB53|cit18","doi-asserted-by":"crossref","first-page":"8317","DOI":"10.1158\/0008-5472.CAN-09-1248","article-title":"The BRAFV600E oncogene induces transforming growth factor beta secretion leading to sodium iodide symporter repression and increased malignancy in thyroid cancer","volume":"69","author":"Riesco-Eizaguirre","year":"2009","journal-title":"Cancer Research"},{"key":"10.1111\/j.1365-2265.2011.04032.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1677\/joe.0.1630495","article-title":"Monoclonal antibodies against the human sodium iodide symporter: utility for immunocytochemistry of thyroid cancer","volume":"163","author":"Castro","year":"1999","journal-title":"The Journal of Endocrinology"},{"key":"10.1111\/j.1365-2265.2011.04032.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"4102","DOI":"10.1210\/jc.83.11.4102","article-title":"Na+\/I- symporter distribution in human thyroid tissues: an immunohistochemical study","volume":"83","author":"Caillou","year":"1998","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1111\/j.1365-2265.2011.04032.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1089\/thy.2006.0174","article-title":"Functional characterization of human thyroid tissue with immunohistochemistry","volume":"17","author":"Faggiano","year":"2007","journal-title":"Thyroid"},{"key":"10.1111\/j.1365-2265.2011.04032.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1677\/ERC-07-0130","article-title":"BRAFV600E mutation, but not RET\/PTC rearrangements, is correlated with a lower expression of both thyroperoxidase and sodium iodide symporter genes in papillary thyroid cancer","volume":"15","author":"Romei","year":"2008","journal-title":"Endocrine-Related Cancer"},{"key":"10.1111\/j.1365-2265.2011.04032.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1677\/erc.1.01119","article-title":"The oncogene BRAF V600E is associated with a high risk of recurrence and less differentiated papillary thyroid carcinoma due to the impairment of Na+\/I- targeting to the membrane","volume":"13","author":"Riesco-Eizaguirre","year":"2006","journal-title":"Endocrine-Related Cancer"},{"key":"10.1111\/j.1365-2265.2011.04032.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/j.1365-2265.2008.03376.x","article-title":"Expression of iodine metabolism genes in human thyroid tissues: evidence for age and BRAFV600E mutation dependency","volume":"70","author":"Espadinha","year":"2009","journal-title":"Clinical Endocrinology (Oxford)"},{"key":"10.1111\/j.1365-2265.2011.04032.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/j.1365-2265.2005.02358.x","article-title":"Prognostic factors and the effect of treatment with radioactive iodine and external beam radiation on patients with differentiated thyroid cancer seen at a single institution over 40\u2003years","volume":"63","author":"Brierley","year":"2005","journal-title":"Clinical Endocrinology (Oxford)"},{"key":"10.1111\/j.1365-2265.2011.04032.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.ecl.2008.02.007","article-title":"An updated systematic review and commentary examining the effectiveness of radioactive iodine remnant ablation in well-differentiated thyroid cancer","volume":"37","author":"Sawka","year":"2008","journal-title":"Endocrinology and Metabolism Clinics of North America"},{"key":"10.1111\/j.1365-2265.2011.04032.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1002\/cncr.21922","article-title":"Diagnostic and extent of disease multigene assay for malignant thyroid neoplasms","volume":"106","author":"Kebebew","year":"2006","journal-title":"Cancer"},{"key":"10.1111\/j.1365-2265.2011.04032.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.suc.2009.06.012","article-title":"Molecular markers in thyroid cancer diagnostics","volume":"89","author":"Kato","year":"2009","journal-title":"Surgical Clinics of North America"},{"key":"10.1111\/j.1365-2265.2011.04032.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1158\/0008-5472.CAN-04-3078","article-title":"Gene expression profile of papillary thyroid cancer: sources of variability and diagnostic implications","volume":"65","author":"Jarzab","year":"2005","journal-title":"Cancer Research"},{"key":"10.1111\/j.1365-2265.2011.04032.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1677\/ERC-06-0048","article-title":"A multi-gene approach to differentiate papillary thyroid carcinoma from benign lesions: gene selection using support vector machines with bootstrapping","volume":"14","author":"Fujarewicz","year":"2007","journal-title":"Endocrine-Related Cancer"},{"key":"10.1111\/j.1365-2265.2011.04032.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0002-9440(10)63272-5","article-title":"Evidence for transcriptional and posttranscriptional alterations of the sodium\/iodide symporter expression in hypofunctioning benign and malignant thyroid tumors","volume":"165","author":"Trouttet-Masson","year":"2004","journal-title":"The American Journal of Pathology"},{"key":"10.1111\/j.1365-2265.2011.04032.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1089\/105072504322880337","article-title":"Lack of correlation for sodium iodide symporter mRNA and protein expression and analysis of sodium iodide symporter promoter methylation in benign cold thyroid nodules","volume":"14","author":"Neumann","year":"2004","journal-title":"Thyroid"},{"key":"10.1111\/j.1365-2265.2011.04032.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1210\/jc.86.6.2697","article-title":"Rapid communication: predominant intracellular overexpression of the Na(+)\/I(-) symporter (NIS) in a large sampling of thyroid cancer cases","volume":"86","author":"Dohan","year":"2001","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1111\/j.1365-2265.2011.04032.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1210\/jc.2002-021544","article-title":"Immunohistochemical profile of the sodium\/iodide symporter in thyroid, breast, and other carcinomas using high density tissue microarrays and conventional sections","volume":"88","author":"Wapnir","year":"2003","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1111\/j.1365-2265.2011.04032.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1210\/jc.87.1.352","article-title":"Benign nonfunctioning thyroid adenomas are characterized by a defective targeting to cell membrane or a reduced expression of the sodium iodide symporter protein","volume":"87","author":"Tonacchera","year":"2002","journal-title":"The Journal of Clinical Endocrinology and Metabolism"}],"container-title":["Clinical Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2265.2011.04032.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2265.2011.04032.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,4]],"date-time":"2021-07-04T22:22:29Z","timestamp":1625437349000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2265.2011.04032.x"}},"subtitle":["Use of NIS expression in DTC"],"short-title":[],"issued":{"date-parts":[[2011,7,6]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,8]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2265.2011.04032.x","relation":{},"ISSN":["0300-0664"],"issn-type":[{"value":"0300-0664","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7,6]]}}}